Evidence map›Paper›PMID 32343504›Full record

ArticleThe New England journal of medicine2020

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Thomas J Oxley, J Mocco, Shahram Majidi, Christopher P Kellner, Hazem Shoirah, I Paul Singh, Reade A De Leacy, Tomoyoshi Shigematsu, Travis R Ladner, Kurt A Yaeger and 6 more

3 registry-linked trialsAbstract readCase ReportsLetter
In one paragraph

Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,225 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,225citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04505774 phase4completednot on this map

A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19

TypeinterventionalSponsorMatthew Neal MDRan2020 to 2024Enrolled3,591ConditionsCovid19Armstheraputic heparin, prophylactic heparin, P2Y12, Crizanlizumab Injection, SGLT2 inhibitor
NCT05019300 unknown statusnot on this mapstarted 2021, after this paper: background citation

Long-term Neurocognitive and Psychiatric Consequences of COVID-19 in Patients Discharged From Critical Care Units. A Cohort Study of the Advance Interdisciplinary Rehabilitation Register (AIRR) Covid-19 Working Group.

TypeobservationalSponsorPontificia Universidad Catolica de ChileRan2021 to 2021Enrolled80ConditionsCovid19, Neurocognitive DysfunctionArmsExposure: COVID-19 severity
NCT05286268 unknown statusnot on this mapstarted 2022, after this paper: background citation

The Role of Ischemia Modified Albumin in Patients With COVID-19

TypeobservationalSponsorLarissa University HospitalRan2022 to 2022Enrolled194ConditionsCOVID-19ArmsIschemia Modified Albumin
3 · Its place in the literature

Who cites it

1,225 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Review
  12. Patient with Acute-On-Chronic Cholecystitis Complicated by Portal Vein Thrombosis Following "Long COVID-19": A Case Report.The International journal of angiology : official publication of the International College of Angiology, Inc · 2026
    Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

1,165 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Thomas J OxleyMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
J MoccoMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Shahram MajidiMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Christopher P KellnerMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.ORCID 0000-0003-4604-8205
Hazem ShoirahMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
I Paul SinghMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Reade A De LeacyMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Tomoyoshi ShigematsuMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.ORCID 0000-0003-3463-0222
Travis R LadnerMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Kurt A YaegerMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Maryna SkliutMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Jesse WeinbergerMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Neha S DangayachMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Joshua B BedersonMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Stanley TuhrimMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.
Johanna T FifiMount Sinai Health System, New York, NY thomas.oxley@mountsinai.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusAdultCoronavirus InfectionsCOVID-19Diabetes ComplicationsFemaleHumansMaleMiddle AgedPandemicsPatient Acceptance of Health CarePneumonia, ViralSARS-CoV-2Severity of Illness IndexStroke

Identifiers

PMID32343504
PMCPMC7207073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.